Presentations, Books, and Publications

  • Brooks JO 3rd, Bonner JC, Rosen AC, Wang PW, Hoblyn JC, Hill SJ, Ketter TA.
    Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression.                                               Psychiatry Res. 2009 Apr 5. [Epub ahead of print]  More »
  • Goldberg JF, Brooks JO 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.                                      Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. 
    J Clin Psychiatry. 2009 Feb;70(2):155-62. Epub 2009 Feb 10. More »  
  • Marsh WK, Ketter TA, Rasgon NL.                                                                                                    
    Increased depressive symptoms in menopausal age women with bipolar disorder: age and gender comparison.

    J Psychiatr Res. 2009 May;43(8):798-802. Epub 2009 Jan 19. More »
  • Perlick DA, Rosenheck RA, Miklowitz DJ, Kaczynski R, Link B, Ketter T, Wisniewski S, Wolff N, Sachs G; STEP-BD Family Experience Collaborative Study Group.                                             
    Caregiver burden and health in bipolar disorder: a cluster analytic approach.
    J Nerv Ment Dis. 2008 Jun;196(6):484-91.  More »      
  • Ketter TA, Brooks JO, Hoblyn JC, Champion LM, Nam JY, Culver JL, Marsh WK, Bonner JC .        
    Effectiveness of lamotrigine in bipolar disorder in a clinical setting. 
    J Psychiatr Res. 2008 Nov;43(1):13-23. More »
  • Ketter TA. 
    Incorporating trial data into bipolar disorder management.                                                                 
    J Clin Psychiatry. 2008 Jul;69(7):e21.  More »
  • Gruber J, Harvey AG, Wang PW, Brooks JO 3rd, Thase ME, Sachs GS, Ketter TA.                       
    Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    J Affect Disord. 2008 Aug 14. More »
  • Benson BE, Willis MW, Ketter TA, Speer A, Kimbrell TA, George MS, Herscovitch P, Post RM.
    Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders.                                                      

    Psychiatry Res. 2008 Oct 30;164(1):30-47. More »
  • Brooks JO 3rd, Hoblyn JC, Woodard SA, Rosen AC, Ketter TA.                                           
    Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder.               

    J Psychiatr Res. 2008 Oct 22.  More »
  • Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L,Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P,Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME.
    Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    N Engl J Med. 2007 Apr 26;356(17):1711-22. More »
  • Cookson J, Keck PE Jr, Ketter TA, Macfadden W.
    Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized,placebo-controlled study.
    Int Clin Psychopharmacol. 2007 Mar;22(2):93-100. More »
  • Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA.
    Enhanced creativity in bipolar disorder patients: a controlled study.
    J Affect Disord. 2007 Jun;100(1-3):31-9. More »
  • Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, NierenbergA, Calabrese J, Wisniewski SR, Sachs G.
    Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
    Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):315-21. More »
  • Strong CM, Nowakowska C, Santosa CM, Wang PW, Kraemer HC, Ketter TA..
    Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals.
    J Affect Disord. 2007 Jun;100(1-3):41-8. Epub 2006 Nov 28 . More »
  • Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R,DeVeaugh-Geiss A, Thompson TR.
    Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Biol Psychiatry. 2006 Jun 1;59(11):1061-4. More »
  • Ketter TA, Greist JH, Graham JA, Roberts JN, Thompson TR, Nanry KP.
    The effect of dermatologic precautions on the incidence of rash with addition of  lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    J Clin Psychiatry. 2006 Mar;67(3):400-6. More »
  • Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, KetterTA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, SachsGS, Thase ME.
    Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Am J Psychiatry. 2006 Feb;163(2):217-24. More »
  • Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, MiklowitzDJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS.
    Treatment-resistant bipolar depression: a STEP-BD equipoise randomizedeffectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Am J Psychiatry. 2006 Feb;163(2):210-6. More »

    Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, TohenM.
    Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic  or mixed episodes.
    J Clin Psychiatry. 2006 Jan;67(1):95-101. More »
  • Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.
    A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Am J Psychiatry. 2005 Jul;162(7):1351-60. More »
  • Ketter TA, Akiskal HS, Keck PE Jr, Fuller MA, Weisler RH, Hirschfeld RM.
    Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
    CNS Spectr. 2005 Jun;10(6 Suppl 5):1-13. More »
  • Ketter TA, Wang PW, Chandler RA, Alarcon AM, Becker OV, Nowakowska C, O'Keeffe CM, Schumacher MR.
    Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash.
    J Clin Psychiatry. 2005 May;66(5):642-5. More »
  • Nowakowska C, Strong CM, Santosa CM, Wang PW, Ketter TA.
    Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls.
    J Affect Disord. 2005 Mar;85(1-2):207-15. More »
  • Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH; SPD417 Study Group.
    Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. 2005 Mar;66(3):323-30. Erratum in: J Clin Psychiatry. 2005
    May;66(5):659. More »
  • Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang HW, Ketter T, Rudorfer MV, Wisniewski SR, Thase ME, Calabrese J, Sachs GS; STEP-BD Investigators.
    Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Bipolar Disord. 2004 Dec;6(6):460-9. More »
  • Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS.
    Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
    Am J Psychiatry. 2004 Oct;161(10):1902-8. More »

    Ketter TA, Wang PW, Nowakowska C, Marsh WK.
    New medication treatment options for bipolar disorders.
    Acta Psychiatr Scand Suppl. 2004;(422):18-33. Review. More »
  • Lembke A, Miklowitz DJ, Otto MW, Zhang H, Wisniewski SR, Sachs GS, Thase ME, Ketter TA; STEP-BD Investigators.
    Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
    J Psychiatr Pract. 2004 Mar;10(2):81-7. More »
  • Ketter TA, Kalali AH, Weisler RH; SPD417 Study Group.
    A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    J Clin Psychiatry. 2004 May;65(5):668-73. More »
  • Wang PW, Ketter TA, Becker OV, Nowakowska C.
    New anticonvulsant medication uses in bipolar disorder.
    CNS Spectr. 2003 Dec;8(12):930-2, 941-7. Review. More »
  • Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang Y.
    Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?
    J Psychiatr Res. 2004 Jan;38(1):47-61. Review. More »
  • Chang K, Steiner H, Ketter T.
    Studies of offspring of parents with bipolar disorder.
    Am J Med Genet C Semin Med Genet. 2003 Nov 15;123(1):26-35. Review. More »
  • Ketter TA, Manji HK, Post RM.
    Potential mechanisms of action of lamotrigine in the treatment of bipolar
    disorders. J Clin Psychopharmacol. 2003 Oct;23(5):484-95. Review. More »
  • Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang YS.
    The diverse roles of anticonvulsants in bipolar disorders.
    Ann Clin Psychiatry. 2003 Jun;15(2):95-108. Review. More »
  • Ketter TA, Wang PW.
    The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders.
    J Clin Psychiatry. 2003;64 Suppl 3:15-20. Review. More »
  • Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA.
    Gabapentin augmentation therapy in bipolar depression.
    Bipolar Disord. 2002 Oct;4(5):296-301. More »
  • Ketter TA, Wang PW.
    Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies.
    J Clin Psychiatry. 2002;63 Suppl 3:21-5. Review. More »
  • Ketter TA, Calabrese JR.
    Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
    J Clin Psychiatry. 2002 Feb;63(2):146-51. Review. More »
  • Lembke A, Ketter TA.
    Impaired recognition of facial emotion in mania.
    Am J Psychiatry. 2002 Feb;159(2):302-4. More »
  • Chang KD, Ketter TA.
    Special issues in the treatment of pediatric bipolar disorder.
    Expert Opin Pharmacother. 2001 Apr;2(4):613-22. Review. More »
  • Wang PW, Ketter TA.
    Biology and recent brain imaging studies in affective psychoses.
    Curr Psychiatry Rep. 2000 Aug;2(4):298-304. Review. More »
  • Callahan AM, Marangell LB, Ketter TA.
    Evaluating the clinical significance of drug interactions: a systematic approach.
    Harv Rev Psychiatry. 1996 Sep-Oct;4(3):153-8. More »
  • Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA.
    The place of anticonvulsant therapy in bipolar illness.
    Psychopharmacology (Berl). 1996 Nov;128(2):115-29. Review. More »

    Ketter, TA, George, MS, Kimbrell, TA, Benson, BE, Post, RM
    Functional brain imaging, limbic function, and affective disorders.
    The Neruoscientist. 1996, Jan; 2(1): 55-65.  More

This website and its contents are designed for informational purposes only and must not be substituted for professional care.